Similarly, Seifert et al. showed that in a GBM tumor, there is higher expression of AKR1B1 and decreased expression of AKR1C1, but there is no difference in the expressions of AKR1C2 or AKR1C3 between the GBM tumor and healthy brain tissue [8]. This evidence concerns the gene AKR1C3 and glioblastoma.